946 PK-PD MODELING OF VIRAL KINETICS DURING TREATMENT WITH DEBIO-025 PLUS PEGYLATED INTERFERON ALPHA-2A IN TREATMENT-NAIVE HCV PATIENTS

2009 ◽  
Vol 50 ◽  
pp. S344 ◽  
Author(s):  
E. Herrmann ◽  
A. Käfer ◽  
R. Flisiak ◽  
V. Nicolas-Métral ◽  
S. Zeuzem ◽  
...  
Keyword(s):  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Viral Kinetics ◽  
Pegylated Interferon Alpha ◽  
Treatment Naïve

Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study

Hepatology ◽  
2012 ◽  
Vol 56 (3) ◽  
pp. 884-893 ◽  
Author(s):  
Michael P. Manns ◽  
Edward Gane ◽  
Maribel Rodriguez-Torres ◽  
Albrecht Stoehr ◽  
Chau-Ting Yeh ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Alpha ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Randomized Phase Ii ◽  
Treatment Naïve

JUMP-C: A randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patients

Hepatology ◽  
2013 ◽  
Vol 58 (2) ◽  
pp. 514-523 ◽  
Author(s):  
Paul J. Pockros ◽  
Donald Jensen ◽  
Naoky Tsai ◽  
Ryan Taylor ◽  
Alnoor Ramji ◽  
...  
Keyword(s):  
Randomized Trial ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Genotype 1 ◽  
Pegylated Interferon Alpha ◽  
Hcv Genotype ◽  
Treatment Naïve ◽  
Hcv Genotype 1
Sign in / Sign up

Export Citation Format

Share Document